Skip to Content
Skip to Navigation

Browse Faculty by
Last Name

Access your account with your UWNetID

James Floyd, MD, MS

Acting Instructor, Department of Medicine (DOM)

Education & Training

MD, Duke University, School of Medicine, Durham, NC, 2005
Internship and Residency in Internal Medicine , University of Washington, Seattle, WA, 2005-2008
MS, University of Washington, School of Public Health, Seattle, WA, 2011

Professional Interests

Cardiovascular drug safety
Epidemiologic methods
Regulatory science


Duke General Clinical Research Center Student Scholarship, 2003
American Heart Association Scholarship in Cardiovascular Disease and Stroke, 2003
American Stroke Association Scholarship in Cerebrovascular Disease, 2003
Duke University William J. Griffith University Service Award, 2005
National Heart Lung Blood Institute K08 Award, 2013

Selected Publications

Floyd JS, Serebruany VL. Prasugrel as a potential cancer promoter: review of the unpublished data. Archives of Internal Medicine. 2010;170:1078-1080. PMID: 20585076.
Floyd JS, Marciante KD, Weiss NS, Heckbert SR, Lumley T, Wiggins KL, Kaspera R, Totah RA, Tamraz B, Kwok P-Y, Psaty BM. A screening case-control study of drug-drug interactions in statin users: a new adverse effect of clopidogrel. Clinical Pharmacology & Therapeutics. 2012;91:896-904. PMID: 22419147.
Floyd JS, Heckbert SR, Carrell DS, Weiss NS, Psaty BM. Use of administrative data to estimate the incidence of statin-related rhabdomyolysis. JAMA. 2012;307:1580-1582. PMID: 22511681. PMCID: PMC3483067.
Floyd JS, Psaty BM. Observational comparative effectiveness studies of drug therapies: High-quality answers or important clinical questions? Archives of Internal Medicine. 2012;172:1412-1414. [invited commentary] PMID: 22928183. PMCID: PMC3597449.
Wheeler S, Moore K, Forsberg CW, Riley K, Floyd JS, Smith NL, Boyko EJ. Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea, or rosiglitazone monotherapy. Diabetologia. 2013;56:1934-1943. PMID: 23797633.